/
/
/

Sun Pharma Advanced Research Company Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--99%2518%
---553%
-6%-8%-7%38%
28%28%52%277%

Peer Comparison

Symbol
PFOCUS
SAGILITY
SYNGENE
HORIZONIND
INDGN
IGIL
NESCO
LEAPIND
SPARC
SMARTWORKS
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
291.55₹22740 Cr196.75-0.5310.52₹301 Cr
46.95₹21885 Cr22.040.463.18₹925 Cr
397.95₹16169 Cr73.16-0.2216.72₹317 Cr
54.67₹16101 Cr0.24-₹198 Cr
605₹14458 Cr36.074.8322.82₹401 Cr
325.85₹14065 Cr23.073.8415.26₹711 Cr
1,052.7₹7366 Cr17.6814.1966.2₹413 Cr
154.72₹6707 Cr107.592.056.05₹62 Cr
200.82₹6572 Cr4.15-0.6449.12₹1553 Cr
541.05₹6095 Cr218.661.1581.21₹11 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
₹40 Cr₹1853 Cr₹8 Cr₹8 Cr₹10 Cr₹27 Cr₹15 Cr₹13 Cr₹17 Cr₹17 Cr₹14 Cr₹21 Cr₹24 Cr₹48 Cr
₹24 Cr₹2 Cr₹0₹1 L₹9 Cr₹0₹19 L₹4 L₹2 Cr₹4 Cr₹6 Cr₹8 Cr₹10 Cr₹11 Cr
₹64 Cr₹1855 Cr₹8 Cr₹8 Cr₹19 Cr₹27 Cr₹15 Cr₹13 Cr₹18 Cr₹21 Cr₹20 Cr₹30 Cr₹34 Cr₹58 Cr
₹76 Cr₹82 Cr₹68 Cr₹76 Cr₹64 Cr₹83 Cr₹92 Cr₹119 Cr₹113 Cr₹125 Cr₹120 Cr₹116 Cr₹129 Cr₹140 Cr
-₹10 Cr₹1775 Cr-₹57 Cr-₹66 Cr-₹43 Cr-₹53 Cr-₹74 Cr-₹103 Cr-₹92 Cr-₹101 Cr-₹96 Cr-₹83 Cr-₹92 Cr-₹79 Cr
₹8 Cr₹12 Cr₹9 Cr₹8 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹56 L₹91 L₹26 L₹26 L₹26 L₹21 L
-₹21 Cr₹1761 Cr-₹80 Cr-₹76 Cr-₹52 Cr-₹61 Cr-₹79 Cr-₹107 Cr-₹96 Cr-₹105 Cr-₹100 Cr-₹86 Cr-₹95 Cr-₹82 Cr
-₹21 Cr₹1761 Cr-₹80 Cr-₹76 Cr-₹52 Cr-₹60 Cr-₹80 Cr-₹107 Cr-₹96 Cr-₹106 Cr-₹100 Cr-₹86 Cr-₹95 Cr-₹82 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023
₹32 Cr₹32 Cr₹32 Cr₹32 Cr
₹1306 Cr-₹249 Cr₹93 Cr₹480 Cr
₹1306 Cr-₹249 Cr₹93 Cr₹480 Cr
₹1339 Cr-₹217 Cr₹126 Cr₹513 Cr
₹0₹100 Cr₹0₹0
-₹2 Cr-₹2 Cr-₹1 Cr₹0
₹66 Cr₹71 Cr₹118 Cr₹130 Cr
₹12 Cr₹8 Cr₹6 Cr₹8 Cr
₹76 Cr₹176 Cr₹123 Cr₹138 Cr
₹97 Cr₹114 Cr₹142 Cr₹148 Cr
₹88 Cr₹94 Cr₹62 Cr₹24 Cr
₹556 Cr₹158 Cr₹47 Cr₹5 L
₹13 Cr₹8 Cr₹14 Cr₹6 Cr
₹754 Cr₹374 Cr₹265 Cr₹179 Cr
₹2169 Cr₹333 Cr₹514 Cr₹830 Cr
₹85 Cr₹85 Cr₹84 Cr₹84 Cr
₹556 Cr₹258 Cr₹47 Cr₹5 L
₹144 Cr₹158 Cr₹157 Cr₹146 Cr
₹59 Cr₹59 Cr₹50 Cr₹40 Cr
₹85 Cr₹99 Cr₹108 Cr₹106 Cr
₹50 L₹56 L₹1 Cr₹2 Cr
₹121 Cr₹128 Cr₹68 Cr₹65 Cr
₹29 Cr₹26 Cr₹25 Cr₹178 Cr
₹306 Cr₹307 Cr₹244 Cr₹375 Cr
₹0₹0₹2 Cr₹291 Cr
₹8 Cr₹16 Cr₹16 Cr₹33 Cr
₹1 Cr₹2 Cr₹155 Cr₹112 Cr
₹1843 Cr₹4 Cr₹42 Cr₹4 Cr
₹10 Cr₹4 Cr₹54 Cr₹16 Cr
₹1862 Cr₹26 Cr₹269 Cr₹455 Cr
₹1108 Cr-₹348 Cr₹4 Cr₹276 Cr
₹2169 Cr₹333 Cr₹514 Cr₹830 Cr
₹41-₹7₹4₹16
₹41-₹7₹4₹16

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023
₹1553 Cr-₹343 Cr-₹387 Cr-₹223 Cr
₹41 Cr₹21 Cr-₹11 Cr₹7 Cr
-₹1865 Cr-₹47 Cr-₹27 Cr₹141 Cr
-₹270 Cr-₹369 Cr-₹425 Cr-₹74 Cr
-₹239 Cr-₹360 Cr-₹429 Cr-₹69 Cr
-₹23 Cr₹158 Cr₹392 Cr-₹548 Cr
₹261 Cr₹199 Cr₹42 Cr₹617 Cr
-₹89 L-₹3 Cr₹5 Cr-₹64 L
₹2 Cr₹5 Cr₹58 L₹1 Cr
₹8 L₹1 L₹20,000₹0
₹1 Cr₹2 Cr₹5 Cr₹58 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)202.50
Volume (₹)2.77 L
High (₹)203.19
Upper Circuit222.79
Low (₹)199.58
Lower Circuit182.29
Prev Close202.54
52W High (₹)289.00
Price200.82
52W Low (₹)108.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)6571.56 Cr
Div. Yield (%)0.00
PE Ratio4.15
Debt to Equity0.42
Price to Book2.78
Book Value41.25
EPS (TTM)48.82
Face Value1.00
ROE (%)276.89

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
PFOCUSNSE
SAGILITYNSE
SYNGENENSE
HORIZONINDNSE
INDGNNSE
IGILNSE
NESCONSE
LEAPINDNSE
SPARCNSE
SMARTWORKSNSE
LTP
1W Low
1W High
Market cap (₹)
291.55-2.85 (-0.97%)
277.50
304.90
22,740Cr
46.95+0.61 (1.32%)
45.82
47.49
21,885Cr
397.95-5.45 (-1.35%)
395.10
407.70
16,169Cr
54.67-3.38 (-5.82%)
53.75
58.30
16,101Cr
605+26.05 (4.50%)
579.85
615.50
14,458Cr
325.85-13.1 (-3.86%)
321.20
347.40
14,065Cr
1052.7+4.3 (0.41%)
1025
1066.80
7,366Cr
154.72-13.68 (-8.12%)
149.50
172.29
6,707Cr
200.82-6.89 (-3.32%)
194.77
207.80
6,572Cr
541.05+2.3 (0.43%)
522
548
6,095Cr

Sun Pharma Advanced Research Company Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹-₹10.34Cr; with other income of ₹23.66Cr, profit before interest and tax came to ₹-₹12.54Cr. Interest expense was ₹8.13Cr; PBT before exceptional items stood at ₹-₹20.67Cr. Basis: consolidated annual results.

Sun Pharma Advanced Research Company Ltd Quaterly Results Key Takeaways

Sun Pharma Advanced Research Company Ltd reported ₹39.92Cr total income from operations in Jun 2026, softer than ₹1853.22Cr in Mar 2026 but higher than ₹9.64Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹-₹10.34Cr; with other income of ₹23.66Cr, profit before interest and tax came to ₹-₹12.54Cr. Interest expense was ₹8.13Cr, taking profit before tax to ₹-₹20.67Cr. After tax of ₹11Lakh, profit after tax stood at ₹-₹20.78Cr (vs ₹1761.34Cr in Mar 2026 and ₹-₹51.87Cr in Jun 2025).